LABinnovatorLABinnovator
COMPANYEVENTSPAST EVENTSPARTNERSCAREERSCONTACT

Patent Portfolios

- Maximising freedom to operate to protect and generate revenue from your patents

Date: January 17 th , 2007
Venue:  Berns Hotel
City: Stockholm, Sweden

In the Chair:

Dr. Giampiero De Luca
Senior Executive Vice President, Licensing & Intellectual Property
SERONO INTERNATIONAL

Hear from your eminent Speaker Panel:

Peter De Weerd
 Vice President and Head of Patents
NOVARTIS INTERNATIONAL

Bart Klein
Executive Vice President Intellectual Property & Legal
CRUCELL

Peter Buhl Jensen
Chief Executive Officer
TOPOTARGET

Frank Landolt
IP and Legal Counsel
ABLYNX

Dr. Neil C. Thomas
Director of Intellectual Property
GENETRIX GROUP

Gerry Kamstra
Partner IP & Life Sciences
BIRD & BIRD

Marianne Johansen
Managing Director
ALBIHNS A/S

Stig Benthin
PhD. Patent Attorney
ZACCO DENMARK

Event Summary:

The life sciences sector is one of the fastest growing industries in the global economy today. The cornerstone of a pharmaceutical or a biotechnology company is its intellectual property. According to an independent survey, the life sciences sector attracted 28 % of all venture capital investments in 2005 or $ 6 billion in 608 deals.

A well-managed Patent Portfolio is being used to protect your R & D, generate revenue, cross-licensing and to enter strategic alliances with partners. In a smaller biotechnology company, one patent can make it all to generate revenue. In a pharmaceutical company, the Patent Portfolio is used to ensure freedom to operate in the global patent landscape.

Through competitive analysis of third party patents, the patent attorneys are able to successfully design-around patent and avoid infringements with your competitors. By optimising the IP value it is possible to make licensing deals with preferred partners at the right time in order to maximise the revenue from your innovations.

This top tier programme is comprehensive and covers the most important key issues to build strong Patent Portfolios in pharmaceutical and biotechnology companies. At this international one-day conference, industry leaders will present detailed case studies to support your company to sustain an advantage in a highly competitive business environment.

This conference will tackle key issues such as:

  • Building efficient Patent Portfolios to optimise your deal making opportunities
  • How to identify and map your competitors and their IPR activities
  • Examining the role of Patent Portfolios to build biotech companies
  • Capitalising on cross-licensing to establish strategic alliances
  • Mastering your IPR strategies to create new business opportunities
  • How to identify partners to establish strategic alliances
  • Patent Portfolios: Quality vs. quantity to generate revenue from your biotech inventions
  • Revenue generator: Long-term licensing vs. up-front payments?
  • Ensuring freedom to operate to attract venture capital
  • Maximising the value on your patent portfolios to enable cross-industry collaboration in the life science community

Target audience and Job Titles:

Presidents, Chief Executive Officers, Chief IP Counsels, Vice Presidents, Directors and Heads of:

  • Intellectual Property
  • Corporate Patents
  • Global Intellectual Property
  • Corporate Intellectual Property
  • Patents - Biotechnology
  • IPR Strategy
  • Legal and Intellectual Property
  • Pharmaceutical Patents
  • Licensing
  • European Patent Attorneys
  • Patent Agents
  • IP Licensing Strategy
  • Litigation & Transaction
  • Business Development
  • Venture Capitalists
  • Patent Agents
  • Partners
  • Consultants
LABinnovator